Safety and Efficacy of Virtual Prosta... - Prostate Cancer N...

Prostate Cancer Network

4,955 members3,087 posts

Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer

dentaltwin profile image
4 Replies

FYI:

jamanetwork.com/journals/ja...

Not sure I like the use of the term "virtual" prostatectomy. Several years ago something called a "brush biopsy" was promoted to dentists. IMO it was NOT a biopsy (though apparently the company was very aggressive in going after anyone who insisted it wasn't); it was cytology.

I don't like the nomenclature; still, if this holds up, it's great.

Written by
dentaltwin profile image
dentaltwin
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Tall_Allen profile image
Tall_Allen

"while in the unfavorable category, the actuarial 4-year PSA relapse-free survival values were 75.0% vs 64.0% (HR, 0.76; 90% CI, 0.17-3.31) for SBRT vs SDRT, respectively." So given the equal toxicity, what is the advantage?

I'm very skeptical of no fractionation based on this:

prostatecancer.news/2017/01...

dentaltwin profile image
dentaltwin in reply to Tall_Allen

Well, yeah. I'm more than a little rusty on my medical statistics, but that's an awful wide confidence interval. Maybe no advantage, other than the convenience, and 4-year relapse-free survival ain't really enough.

Tall_Allen profile image
Tall_Allen in reply to dentaltwin

You are right that it is statistically not different,but the sample was underpowered to detect a difference. Even if they are the same - I can't see any advantage - 5 10-minute treatments was really nothing, and the more mature, multi-institutional clinical data on HDR brachy and the radiobiology theory indicates a risk.

cesces profile image
cesces

Interesting. But not quite ready for prime time.

You may also like...

Should SBRT be THE preferred treatment for intermediate risk prostate cancer?

(if available) or brachy boost therapy otherwise....

SBRT has excellent outcomes for intermediate risk patients

highest rates of potency preservation of any therapy....

Risk of second primary cancer after primary radiotherapy for PC

would likely be more meaningful. Note that the lead author is a RO. https://jamanetwork.com/journa

No difference in SBRT vs conventionally fractionated radiation for intermediate risk patients

effects. https://www.prostatecancer.news/2019/02/sbrt-has-non-inferior-acute-and-late.html...

Prostate Cancer Will Recur in 40%-50% of Patients After Initial Treatment

the reduced side effects. Anyone care to comment?...